Liporase injection
Hyaluronidase 1,500IU (lyophilization)
Negotiable Min Order Quantity 1000 Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Liporase injection
- Payment Terms
- T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- lyophilization, liporase, hyaluronidase, daehan new pharm
- Category
- Beauty , Health Products , Pharmaceuticals , Medicines , Other Pharmaceuticals
Daehan Nupharm Co., Ltd.
- Recent Visit
- Dec 02, 2024
- Country / Year Established
-
South Korea
/
1984
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | Liporase injection | Certification | - |
|---|---|---|---|
| Category |
Beauty
Health Products Pharmaceuticals Medicines Other Pharmaceuticals |
Ingredients | HYALURONIDASE |
| Keyword | lyophilization , liporase , hyaluronidase , daehan new pharm | Unit Size | 7.8 * 3.1 * 3.8 cm |
| Brand name | Liporase injection | Unit Weigh | 60 g |
| origin | South Korea | Stock | 1000 |
| Supply type | Available | HS code | 300490 |
Product Information
Daehan Nupharm (Daehan New Pharm) is a manufacturer of the product.
The product is manufactured in accordance with the Good Manufacturing Practice (GMP).
Active ingredient
Hyaluronidase 1,500IU
Description
Lyophilized white powder in a vial
Indication
1) Increased penetration by subcutaneous or intramuscular injection, local anesthetic and subcutaneous injection
2) Promoting reabsorption of excess body fluids and blood in tissues
Administration / Dosage
For subcutaneous injection (mass subcutaneous injection): dissolve 1 vial in 1mL of water for injection or saline injection and inject it into the affected area before starting subcutaneous injection
Storage
Store in hermetic container at the room temperature (below 25℃).
Shelf life
36 months from the manufacturing date
Packing unit
10 vials / Box
Packing unit
10 vials / Box
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Ocean Shipping |
|---|---|---|---|
| MOQ | 1000 | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Wanjin Lee
- Address
- Hyangnam-eup, Jeyakgongdan 1-gil,66, Hwaseong-si, Gyeonggi-do, Korea
- Year Established
- 1984
- No. of Total Employees
- 101-500
- Company introduction
-
Founded in 1984, Daehan New Pharm is a KOSDAQ-listed biopharmaceutical company that started with animal feed additives and veterinary medicine business, expanded to human medicine business in 1994, bio business in 2012, and medical device business in 2014.
Daehan New Pharm, which is continuously growing based on the management philosophy of ‘creating values that can be shared by people with health and warmth,’ is showing remarkable growth, achieving sales of 166.5 billion won in 2021 and a CAGR of 15% over the past 10 years. In addition, Daehan New Pharm has been exporting more than 10 billion won every year since winning the ‘$10 Million Dollar Export Award’ in 2015.
Daehan New Pharm is expanding the R&D pipeline to launch a variety of dietary supplements, and are conducting research and development of differentiated high-quality raw ingredients and formulations.
In order to secure future growth engines in the divisions of dietary supplement, human medicine, veterinary medicine, and bio, Daehan New Pharm Industry-University-Research Center was built in Pangyo 2nd Techno Valley in 2021, and the central research center in Hwaseong and the bio research center in Osong were moved to Pangyo for R&D capabilities to create synergies between the business divisions.
- Main Product
- Attached File
